Detection and characterization of circulating and disseminated prostate cancer cells.
about
Circulating tumor cells: approaches to isolation and characterizationDetection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevanceCirculating tumors cells as biomarkers: progress toward biomarker qualificationDynamic changes in numbers and properties of circulating tumor cells and their potential applicationsTargeting bone physiology for the treatment of metastatic prostate cancerProstate cancer and parasitism of the bone hematopoietic stem cell nicheTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayCirculating Tumor Cell Isolation and Analysis.Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.Structure and function of the solid tumor niche.The prostate cancer bone marrow niche: more than just 'fertile soil'.Models, mechanisms and clinical evidence for cancer dormancy.Circulating tumor cells: detection, molecular profiling and future prospects.Cadherin-11 promotes the metastasis of prostate cancer cells to bone.Role of the EpCAM (CD326) in prostate cancer metastasis and progression.The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter.Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells.Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood.Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer.Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
P2860
Q24631347-519B15CA-18A0-423C-A9D6-8AE5C42D3560Q24646761-F5E0BC38-1EBF-46A0-AA9C-E2033DBD7AE8Q26852579-4A0E7889-3662-4EDF-8264-D3AE3F3D1601Q26853569-BC6AC3DA-5675-44FD-9A47-9CA630DB5B50Q26863249-E244D931-2FB0-4D92-B536-3BC35FA87414Q26996231-79AD9D11-0585-4A82-BB47-CA47234AF96DQ28382812-26DAD89D-AE7D-45BD-83E1-F6321386A62CQ30358229-F5E7BB64-85B0-4C17-9B8B-E19C4808DBA6Q30438167-0EA78550-D44A-47D4-88A6-7772BAAF8B0DQ35632622-D5316410-960A-48EF-B6D5-1A65BE091A5BQ36676448-FFAA81E5-7CA0-44EC-BD83-F2C30527362BQ36700788-193FFD19-284E-4400-8085-C5FD75A37D85Q36844303-EAC68037-38D7-4E12-91E2-D29194CC27B6Q37027492-285D80C2-CD23-4F42-9D38-01FA473C1A55Q37100123-AC71DB86-41CC-4C6C-A47A-07591D7F517FQ38020426-8AB92D0D-17FE-4F57-AF20-68855DE967FDQ38213416-5C667457-ED10-458E-95FA-AEEED5B4CC28Q38263525-776D559B-5B0C-40D0-9621-6BF4E5332023Q38461768-EA829C37-24F0-4756-9976-D1F01954A735Q38494213-69013F71-46AA-4A76-9E39-5CCCF246B269Q39685575-0968772E-C593-4343-A74E-16139B4F4EE0Q41786029-A0516281-C5BF-40E3-9A21-2104154FA6B6Q49645514-DB7E912B-A20B-4E8B-A013-6C55611955DF
P2860
Detection and characterization of circulating and disseminated prostate cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Detection and characterization of circulating and disseminated prostate cancer cells.
@ast
Detection and characterization of circulating and disseminated prostate cancer cells.
@en
type
label
Detection and characterization of circulating and disseminated prostate cancer cells.
@ast
Detection and characterization of circulating and disseminated prostate cancer cells.
@en
prefLabel
Detection and characterization of circulating and disseminated prostate cancer cells.
@ast
Detection and characterization of circulating and disseminated prostate cancer cells.
@en
P2093
P356
P1476
Detection and characterization of circulating and disseminated prostate cancer cells.
@en
P2093
Paul H Lange
Robert L Vessella
Todd M Morgan
P304
P356
10.2741/2290
P577
2007-05-01T00:00:00Z